219
Views
2
CrossRef citations to date
0
Altmetric
Articles

Time for effective cycloplegia in patients with brown iris

ORCID Icon, , ORCID Icon, , ORCID Icon, , & show all

References

  • Morgan IG, Iribarren R, Fotouhi A, Grzybowski A. Cycloplegic refraction is the gold standard for epidemiological studies. Acta Ophthalmol. 2015;93(6):581–585. doi:10.1111/aos.12642.
  • Zhao J, Mao J, Luo R, Li F, Pokharel GP, Ellwein LB. Accuracy of noncycloplegic autorefraction in school-age children in China. Optometry Vision Sci. 2004;81(1):49–55. doi:10.1097/00006324-200401000-00010.
  • Sankaridurg P, He X, Naduvilath T, et al. Comparison of noncycloplegic and cycloplegic autorefraction in categorizing refractive error data in children. Acta Ophthalmol. 2017;95(7):e633–e640. doi:10.1111/aos.13569.
  • Yazdani N, Sadeghi R, Momeni-Moghaddam H, Zarifmahmoudi L, Ehsaei A. Comparison of cyclopentolate versus tropicamide cycloplegia: a systematic review and meta-analysis. J Optom. 2018;11(3):135–143. doi:10.1016/j.optom.2017.09.001.
  • Salvesen S, Køhler M. Automated refraction. Acta Ophthalmol. 1991;69(3):342–346. doi:10.1111/j.1755-3768.1991.tb04825.x.
  • Kovacić Z, Ivanisević M, Plestina-Borjan I, Capkun V. Automatic refractometry, reliability of the determination of type and degree of refraction anomalies. LijecVjesn. 1998;120:162–164.
  • Kyei S, Nketsiah AA, Asiedu K, Awuah A, Owusu-Ansah A. Onset and duration of cycloplegic action of 1% cyclopentolate — 1% tropicamide combination. Afr Health Sci. 2017;17(3):923–932. doi:10.4314/ahs.v17i3.36.
  • Manny RE, Fern KD, Zervas HJ, et al. 1% Cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response. Optometry Vision Sci. 1993;70(8):651–665. doi:10.1097/00006324-199308000-00013.
  • van Minderhout HM, Joosse MV, Grootendorst DC, Schalij-Delfos NE. A randomized clinical trial using atropine, cyclopentolate, and tropicamide to compare refractive outcome in hypermetropic children with a dark iris; skin pigmentation and crying as significant factors for hypermetropic outcome. Strabismus. 2019;27(3):127–138. doi:10.1080/09273972.2019.1629466.
  • Laojaroenwanit S, Layanun V, Praneeprachachon P, Pukrushpan P. Time of maximum cycloplegia after instillation of cyclopentolate 1% in children with brown irises. OPTH. 2016;10:897–902. doi:10.2147/OPTH.S102611.
  • Lin LL-K, Shih Y-F, Hsiao C-H, Su T-C, Chen C-J, Hung PT. The cycloplegic effects of cyclopentolate and tropicamide on myopic children. J Ocul Pharmacol Ther. 1998;14(4):331–335. doi:10.1089/jop.1998.14.331.
  • Ebri A, Kuper H, Wedner S. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in Nigerian children. Invest Ophthalmol Vis Sci. 2007;48(3):1025–1031. doi:10.1167/iovs.06-0604.
  • Sun FC, Stark L, Nguyen A, Wong J, Lakshminarayanan V, Mueller E. Changes in accommodation with age: static and dynamic. Am J Optom Physiol Opt. 1988;65(6):492–498. doi:10.1097/00006324-198806000-00009.
  • Momeni-Moghaddam H, Kundart J, Askarizadeh F. Comparing measurement techniques of accommodative amplitudes. Indian J Ophthalmol. 2014;62(6):683–687. doi:10.4103/0301-4738.126990.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.